Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Statement Of Investor Complaints For The Quarter Ended September 2022

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- Charandeep Singh SalujaDesignation :- Company Secretary and Compliance Officer
10-10-2022
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

With reference to the captioned subject, please find enclosed herewith the intimation dated 10th October, 2022 received from Link lntime India Private Limited, Registrar and Share Transfer Agent, regarding approval of the request received for issue of Duplicate Share Certificate(s) and issue of letter of confirmation in lieu of the physical share certificate to the registered shareholder(s) and/or their legal heir(s) in accordance with the provisions of SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated 25th January, 2022. We request you to kindly take the same on record.
10-10-2022
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Closure of Trading Window

With reference to the captioned matter, this is to inform the exchange that in terms of the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons and their Immediate Relatives framed pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company will remain closed from 1st October, 2022 till 48 hours after the declaration of the unaudited financial results for the quarter and half year ended 30th September, 2022. The date of the Board Meeting for inter alia considering the unaudited financial results for the quarter and half year ended 30th September, 2022 will be intimated in due course. We request you to kindly take the same on record.
30-09-2022
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

With reference to the captioned subject, please find enclosed herewith the intimation dated 27th September, 2022 received from Link lntime India Private Limited, Registrar and Share Transfer Agent, regarding receipt of the request(s)/application(s) from the registered shareholder(s) of the Company for issue of Duplicate Share Certificate(s).
27-09-2022
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication

We enclose herewith a copy of the notice published in English and vernacular language (Gujarati) newspaper on 21st September, 2022 in Economic Times and Indian Express, English Edition and Financial Express Gujarati Edition informing the members inter alia about the schedule of 12th Annual General Meeting of the Company, dispatch of Annual Report for F.Y. 2021-22 and procedure for voting.
21-09-2022
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

With reference to the captioned subject, please find enclosed herewith the intimation dated 20th September, 2022 received from Link lntime India Private Limited, Registrar and Share Transfer Agent, regarding receipt of the request(s)/application(s) from the registered shareholder(s) of the Company for issue of Duplicate Share Certificate(s). We request you to kindly take the same on record.
20-09-2022
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - 12Th Annual General Meeting Of The Company To Be Held On 11Th November, 2022.

Notice of 12th Annual General Meeting of the Members of the Company scheduled to be held on Friday, the 11th November, 2022 at 3:00 p.m. IST through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM'). We request you to kindly take the same on record.
19-09-2022
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Reg. 34 (1) Annual Report.

Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of the Annual Report of the Company for the financial year ended 31st March, 2022. We request you to kindly take the same on record.
19-09-2022
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Submission Of Notice Of 12Th Annual General Meeting Of The Company

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith Notice of 12th Annual General Meeting of the Members of the Company scheduled to be held on Friday, the 11th November, 2022 at 3:00 p.m. IST through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM'). We request you to kindly take the same on record.
19-09-2022
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of the advance notice published in English and vernacular language (Gujarati) newspaper on 16th September, 2022 in Economic Times and Indian Express, English Edition and Financial Express Gujarati Edition, in compliance with Ministry of Corporate Affair's General Circular No. 20/2020 dated 5th May, 2020 inter alia informing the members that the 12th Annual General Meeting of the Company will be held on Friday, the 11th November, 2022 through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM'). We request you to kindly take the same on record.
16-09-2022
Next Page
Close

Let's Open Free Demat Account